SCHEMBL2655997

SCHEMBL2655997

Cc1cc(OCCC(C)Cc2ccc(C(=O)NCCC(=O)O)cc2)cc(C)c1-c1ccc(C(C)(C)C)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GCGR P47871 17/20 0.61
ADCY6 O43306 7/20 0.49
ADCY3 O60266 7/20 0.49
ADCY9 O60503 7/20 0.49
ADCY5 O95622 7/20 0.49
ADCY8 P40145 7/20 0.49
ADCY7 P51828 7/20 0.49
ADCY2 Q08462 7/20 0.49
ADCY1 Q08828 7/20 0.49
ADCY4 Q8NFM4 7/20 0.49
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
CASP3 P42574 1/20 0.46
RAB9A P51151 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
EPHX2 P34913 1/20 0.44
NR1H4 Q96RI1 1/20 0.44
GCG P01275 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655157 0.92 GCGR (0.60) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2655051 0.92 GCGR (0.55) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2653753 0.91 GCGR (0.60) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2656634 0.91 GCGR (0.50) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2655329 0.87 GCGR (0.61) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2655617 0.86 GCGR (0.61) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2653091 0.85 GCGR (0.53) GCGRGCG
SCHEMBL1765233 0.85 GCGR (0.63) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2654611 0.85 GCGR (0.59) GCGRADCY6ADCY3ADCY9ADCY5
SCHEMBL2656001 0.84 GCGR (0.51) GCGRNPC1POLBCASP3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951659-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Eli Lilly & Company (US) 2008-08-06 EP claimed
WO-2007114855-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-10-11 WO claimed
EP-1951659-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Eli Lilly & Company (US) 2008-08-06 EP disclosed
WO-2007114855-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-10-11 WO disclosed